Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Comparative Analysis of Tenogenic Gene Expression in Tenocyte-Derived Induced Pluripotent Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells in Response to Biochemical and Biomechanical Stimuli

Yang F., Richardson DW.

Laboratory Study on Tendon Injury, published in Stem Cells Int (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Stem Cells Int (2021)
Reported sample size
—
Source database
Europe PMC
PMID
33510795
PMCID
PMC7825360
DOI
10.1155/2021/8835576
Citations
12

Abstract (original English)

The tendon is highly prone to injury, overuse, or age-related degeneration in both humans and horses. Natural healing of injured tendon is poor, and cell-based therapeutic treatment is still a significant clinical challenge. In this study, we extensively investigated the expression of tenogenic genes in equine bone marrow mesenchymal stem cells (BMSCs) and tenocyte-derived induced pluripotent stem cells (teno-iPSCs) stimulated by growth factors (TGF- β 3 and BMP12) combined with ectopic expression of tenogenic transcription factor MKX or cyclic uniaxial mechanical stretch. Western blotting revealed that TGF- β 3 and BMP12 increased the expression of transcription factors SCX and MKX in both cells, but the tenocyte marker tenomodulin (TNMD) was detected only in BMSCs and upregulated by either inducer. On the other hand, quantitative real-time PCR showed that TGF- β 3 increased the expression of EGR1 , COL1A2 , FMOD , and TNC in BMSCs and SCX , COL1A2 , DCN , FMOD , and TNC in teno-iPSCs. BMP12 treatment elevated SCX , MKX , DCN , FMOD , and TNC in teno-iPSCs. Overexpression of MKX increased SCX , DCN , FMOD , and TNC in BMSCs and EGR1 , COL1A2 , DCN , FMOD , and TNC in teno-iPSCs; TGF- β 3 further enhanced TNC in BMSCs. Moreover, mechanical stretch increased SCX , EGR1 , DCN , ELN , and TNC in BMSCs and SCX , MKX , EGR1 , COL1A2 , DCN , FMOD , and TNC in teno-iPSCs; TGF- β 3 ten

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research